JF
LFCR icon

Jump Financial’s Lifecore Biomedical LFCR Stock Holding History

Jump Financial’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,061
Closed -$123K – 2173
2025
Q4 		$123K Buy
+15,061
New +$111K ﹤0.01% 1813
2024
Q4 		– Sell
-22,147
Closed -$109K – 1846
2024
Q3 		$109K Buy
+22,147
New +$116K ﹤0.01% 1523
2023
Q4 		– Sell
-36,918
Closed -$279K – 2024
2023
Q3 		$279K Buy
+36,918
New +$337K 0.01% 1351
2023
Q1 		– Sell
-12,200
Closed -$79.1K – 1833
2022
Q4 		$79.1K Buy
+12,200
New +$101K ﹤0.01% 1455
2022
Q1 		– Sell
-10,756
Closed -$119K – 1735
2021
Q4 		$119K Buy
+10,756
New +$104K 0.01% 1204

Other funds holding LFCR

2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GC
Grizzlyrock Capital Chicago, Illinois $143M AUM 6.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jump Financial's LFCR Position: Q1 2026 in Review

Jump Financial sold out of Lifecore Biomedical (LFCR) in Q1 2026, closing a stake of 15,061 shares — an estimated $123K sold.

Jump Financial first reported a position in LFCR in Q4 2021 and held it in 5 quarters. The position peaked at $279K in Q3 2023. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Jump Financial reported no remaining Lifecore Biomedical position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 15,061 Lifecore Biomedical shares in Q1 2026, an estimated $123K.
  • Jump Financial first reported a position in Lifecore Biomedical in Q4 2021 and held it in 5 quarters.
  • Jump Financial's Lifecore Biomedical position peaked at $279K in Q3 2023.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.